Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically ...

The breakthrough, published Tuesday in the journal Cell, offers a promising new strategy to combat relapse, which occurs in more than half of patients following CAR-T therapy. The approach works by ...

Large granular lymphocytic leukemias (LGLLs) are a heterogeneous group of rare chronic lymphoproliferative disorders characterized by the clonal proliferation of cytotoxic lymphocytes. Among them, ...

Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric ...

When the immune system starts damaging healthy tissues, autoimmune diseases can develop. These conditions can affect many parts of the body, including the joints, bone marrow, skin, and organs.

A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...

Has come back (relapsed) within a year of treatment or does not go away (refractory) after your first treatment Has relapsed or is refractory and you cannot receive a hematopoietic stem cell ...

Acute myeloid leukemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in those over 65. Around 150 people are diagnosed with the disease each year in ...